Biodegradable Pharmaceutical Packaging Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4166062
- 108 Pages
- January 2021
- Diagnostic and Biotech
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Biodegradable Pharmaceutical Packaging market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Biodegradable Pharmaceutical Packaging market segmented into
Small Molecule
Large Molecule (Biologics)
Based on the end-use, the global Biodegradable Pharmaceutical Packaging market classified into
Solid Packaging
Liquid Packaging
Based on geography, the global Biodegradable Pharmaceutical Packaging market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Gerresheimer
Berry Plastics Corporation
DS Smith
Rengo
Bemis Company
Smurfit Kappa
Amcor
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIODEGRADABLE PHARMACEUTICAL PACKAGING INDUSTRY
2.1 Summary about Biodegradable Pharmaceutical Packaging Industry
2.2 Biodegradable Pharmaceutical Packaging Market Trends
2.2.1 Biodegradable Pharmaceutical Packaging Production & Consumption Trends
2.2.2 Biodegradable Pharmaceutical Packaging Demand Structure Trends
2.3 Biodegradable Pharmaceutical Packaging Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Small Molecule
4.2.2 Large Molecule (Biologics)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Solid Packaging
4.3.2 Liquid Packaging
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Small Molecule
5.2.2 Large Molecule (Biologics)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Solid Packaging
5.3.2 Liquid Packaging
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Small Molecule
6.2.2 Large Molecule (Biologics)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Solid Packaging
6.3.2 Liquid Packaging
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Small Molecule
7.2.2 Large Molecule (Biologics)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Solid Packaging
7.3.2 Liquid Packaging
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Small Molecule
8.2.2 Large Molecule (Biologics)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Solid Packaging
8.3.2 Liquid Packaging
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Small Molecule
9.2.2 Large Molecule (Biologics)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Solid Packaging
9.3.2 Liquid Packaging
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Gerresheimer
10.1.2 Berry Plastics Corporation
10.1.3 DS Smith
10.1.4 Rengo
10.1.5 Bemis Company
10.1.6 Smurfit Kappa
10.1.7 Amcor
10.2 Biodegradable Pharmaceutical Packaging Sales Date of Major Players (2017-2020e)
10.2.1 Gerresheimer
10.2.2 Berry Plastics Corporation
10.2.3 DS Smith
10.2.4 Rengo
10.2.5 Bemis Company
10.2.6 Smurfit Kappa
10.2.7 Amcor
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Biodegradable Pharmaceutical Packaging Product Type Overview
2.Table Biodegradable Pharmaceutical Packaging Product Type Market Share List
3.Table Biodegradable Pharmaceutical Packaging Product Type of Major Players
4.Table Brief Introduction of Gerresheimer
5.Table Brief Introduction of Berry Plastics Corporation
6.Table Brief Introduction of DS Smith
7.Table Brief Introduction of Rengo
8.Table Brief Introduction of Bemis Company
9.Table Brief Introduction of Smurfit Kappa
10.Table Brief Introduction of Amcor
11.Table Products & Services of Gerresheimer
12.Table Products & Services of Berry Plastics Corporation
13.Table Products & Services of DS Smith
14.Table Products & Services of Rengo
15.Table Products & Services of Bemis Company
16.Table Products & Services of Smurfit Kappa
17.Table Products & Services of Amcor
18.Table Market Distribution of Major Players
19.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
20.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
21.Table Global Biodegradable Pharmaceutical Packaging Market Forecast (Million USD) by Region 2021f-2026f
22.Table Global Biodegradable Pharmaceutical Packaging Market Forecast (Million USD) Share by Region 2021f-2026f
23.Table Global Biodegradable Pharmaceutical Packaging Market Forecast (Million USD) by Demand 2021f-2026f
24.Table Global Biodegradable Pharmaceutical Packaging Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
